TRIGLIDE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Triglide, and when can generic versions of Triglide launch?

Triglide is a drug marketed by Skyepharma Ag and is included in one NDA.

The generic ingredient in TRIGLIDE is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Triglide

A generic version of TRIGLIDE was approved as fenofibrate by RHODES PHARMS on May 13^th, 2005.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TRIGLIDE?
What are the global sales for TRIGLIDE?
What is Average Wholesale Price for TRIGLIDE?

Summary for TRIGLIDE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	138
Clinical Trials:	3
Patent Applications:	4,095
Drug Prices:	Drug price information for TRIGLIDE
DailyMed Link:	TRIGLIDE at DailyMed

Drug patent expirations by year for TRIGLIDE

Recent Clinical Trials for TRIGLIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Lindsay Ferguson, MD	Phase 1
Medical University of South Carolina	Phase 4
National Institutes of Health (NIH)	N/A

See all TRIGLIDE clinical trials

US Patents and Regulatory Information for TRIGLIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Skyepharma Ag	TRIGLIDE	fenofibrate	TABLET;ORAL	021350-001	May 7, 2005		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Skyepharma Ag	TRIGLIDE	fenofibrate	TABLET;ORAL	021350-002	May 7, 2005	BX	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TRIGLIDE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Skyepharma Ag	TRIGLIDE	fenofibrate	TABLET;ORAL	021350-001	May 7, 2005	⤷ Sign Up	⤷ Sign Up
Skyepharma Ag	TRIGLIDE	fenofibrate	TABLET;ORAL	021350-002	May 7, 2005	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TRIGLIDE

See the table below for patents covering TRIGLIDE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	2423335	PROCEDE DE SECHAGE PAR ATOMISATION ET COMPOSITIONS DE FENOFIBRATE (SPRAY DRYING PROCESS AND COMPOSITIONS OF FENOFIBRATE)	⤷ Sign Up
Taiwan	I354568		⤷ Sign Up
Japan	2005535582		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for TRIGLIDE

Recent Clinical Trials for TRIGLIDE

Make Better Decisions: Try a trial or see plans & pricing